Madrigal Pharmaceuticals Inc

MDGLNASDAQ · USD
517.64USD-13.88 (-2.62%)
239

Madrigal Pharmaceuticals Inc (MDGL) Implied Volatility Current

MDGL implied volatility is 44%. IV Rank is 14%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking MDGL implied volatility helps you identify when options premiums on Madrigal Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Madrigal Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when MDGL IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Madrigal Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For MDGL, tracking metrics like MDGL IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on MDGL signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where MDGL implied volatility sits today versus where it has been. Our scanner ranks Madrigal Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in MDGL IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Madrigal Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
14.29%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)44.31%

IV Rank14.29%

Historical Volatility (30d)35.36%

IV - HV+8.95%

As of September 18, 2026

Trade options with IV on your side

Track MDGL IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial